- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/22 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or in which the condensed system contains four or more hetero rings
Patent holdings for IPC class C07D 513/22
Total number of patents in this class: 285
10-year publication summary
|
14
|
12
|
5
|
10
|
12
|
27
|
25
|
42
|
40
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1595 |
16 |
| Merck Patent GmbH | 5873 |
13 |
| Revolution Medicines, Inc. | 233 |
13 |
| Gilead Sciences, Inc. | 2031 |
12 |
| Hoffmann-La Roche Inc. | 3404 |
9 |
| Janssen Pharmaceutica N.V. | 3396 |
9 |
| Hangzhou DAC Biotech Co., Ltd | 102 |
8 |
| F. Hoffmann-La Roche AG | 7934 |
7 |
| Sumitomo Chemical Company, Limited | 9031 |
7 |
| Raynergy Tek Inc. | 109 |
5 |
| Bristol-myers Squibb Company | 4879 |
4 |
| Massachusetts Institute of Technology | 10030 |
4 |
| Genzyme Corporation | 1242 |
4 |
| University of Sharjah | 46 |
4 |
| Nuvalent, Inc. | 57 |
4 |
| Novartis AG | 10886 |
3 |
| FUJIFILM Corporation | 29295 |
3 |
| The Regents of the University of Michigan | 4676 |
3 |
| Osaka University | 3377 |
3 |
| Rohm and Haas Electronic Materials Korea Ltd. | 330 |
3 |
| Other owners | 151 |